PGHL
Procter & Gamble Health Ltd. (PGHL)
Market Closed
28 Jul, 10:00
XNSE XNSE Primary MSE ₹
5,851. 50
+41
+0.71%
₹
- Market Cap
- P/E Ratio
800% Div Yield
6,160 Volume
- Eps
₹ 5,810.5
Previous Close Day Range
5,817.5 5,946
Year Range
4,863 6,175.5
Want to track PGHL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 22 days
Summary
PGHL closed today higher at ₹5,851.5, an increase of 0.71% from yesterday's close, completing a monthly increase of or ₹5,851.5. Over the past 12 months, PGHL stock gained .
PGHL pays dividends to its shareholders, with the most recent payment made on Mar 07, 2025. The next announced payment will be in In 1 month on Sep 25, 2025 for a total of ₹45.
The last earnings report, released on May 29, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports. The next scheduled earnings report is due on Aug 19, 2025.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on XNSE (INR).
PGHL Chart
Procter & Gamble Health Ltd. Dividends
| PGHL PGHL In 3 weeks Announced | Semi Annual | ₹45 Per Share |
| PGHL PGHL 5 months ago Paid | Other | ₹80 Per Share |
| PGHL PGHL 8 months ago Paid | Other | ₹60 Per Share |
| PGHL PGHL 14 Feb 2024 Paid | Other | ₹50 Per Share |
| PGHL PGHL 23 Nov 2023 Paid | Other | ₹50 Per Share |
Procter & Gamble Health Ltd. Earnings
| 19 Aug 2025 (In 3 weeks) Date | | - Cons. EPS | - EPS |
| 29 May 2025 Date | | - Cons. EPS | - EPS |
| 30 Apr 2025 Date | | - Cons. EPS | - EPS |
| 4 Feb 2025 Date | | - Cons. EPS | - EPS |
| 4 Nov 2024 Date | | - Cons. EPS | - EPS |
| PGHL PGHL In 3 weeks Announced | Semi Annual | ₹45 Per Share |
| PGHL PGHL 5 months ago Paid | Other | ₹80 Per Share |
| PGHL PGHL 8 months ago Paid | Other | ₹60 Per Share |
| PGHL PGHL 14 Feb 2024 Paid | Other | ₹50 Per Share |
| PGHL PGHL 23 Nov 2023 Paid | Other | ₹50 Per Share |
| 19 Aug 2025 (In 3 weeks) Date | | - Cons. EPS | - EPS |
| 29 May 2025 Date | | - Cons. EPS | - EPS |
| 30 Apr 2025 Date | | - Cons. EPS | - EPS |
| 4 Feb 2025 Date | | - Cons. EPS | - EPS |
| 4 Nov 2024 Date | | - Cons. EPS | - EPS |
Procter & Gamble Health Ltd. (PGHL) FAQ
What is the stock price today?
The current price is ₹5,851.50.
On which exchange is it traded?
Procter & Gamble Health Ltd. is listed on XNSE.
What is its stock symbol?
The ticker symbol is PGHL.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 800%.
What is its market cap?
As of today, no market cap data is available.
When is the next earnings date?
The next earnings report will release on Aug 19, 2025.
Has Procter & Gamble Health Ltd. ever had a stock split?
No, there has never been a stock split.
Procter & Gamble Health Ltd. Profile
| Drug Manufacturers—Specialty & Generic Industry | Healthcare Sector | - CEO | XNSE Exchange | INE199A01012 ISIN |
| India Country | 1,407 Employees | 22 Aug 2025 Last Dividend | - Last Split | - IPO Date |
Overview
Procter & Gamble Health Limited, formerly known as Merck Limited, represents a significant force in the pharmaceuticals and chemical products industry both within India and on an international scale. With a history that dates back to its incorporation in 1967, the company has developed a strong presence in the healthcare sector. Headquartered in Mumbai, India, Procter & Gamble Health Limited provides a wide array of over-the-counter products, vitamins, minerals, and supplements, catering to various health needs and conditions. This enterprise was rebranded from Merck Limited to its current name in May 2019, marking a new chapter in its history. As a subsidiary of Procter & Gamble Overseas India BV, it continues to expand its influence and commitment to improving health and well-being around the globe.
Products and Services
Procter & Gamble Health Limited offers a diverse portfolio of health-related products, distinguished by their quality and the trust they have garnered from consumers worldwide. The product range includes:
- Cosome: A brand known for its therapeutic products, particularly in the respiratory space, aiming at providing relief for cough and cold symptoms.
- Polybion: A line of multivitamin and mineral supplements designed to support overall health and well-being, prominently utilized for enhancing energy levels and addressing nutritional deficiencies.
- Neurobion: Recognized for its contribution to nerve health, Neurobion consists of supplements rich in B vitamins, crucial for maintaining nerve integrity and ensuring optimal nerve function.
- Evion: A vitamin E supplement brand, Evion is tailored towards promoting skin health and providing antioxidant protection against free radicals, thereby supporting cellular health.
- Nasivion: Specializing in nasal care, Nasivion offers a range of products aimed at alleviating nasal congestion and facilitating better breathing.
- Livogen: This brand focuses on iron supplementation, addressing iron-deficiency anemia and related health concerns through its well-formulated products.
- Seven Seas: A historic brand that offers a variety of supplements, including cod liver oil, known for its omega-3 fatty acids, vitamins A and D, contributing to heart health, bone maintenance, and immune system support.
Contact Information
Address: P&G Plaza
Phone: 91 22 6866 9000
Website: https://www.pghealthindia.com
2025 © Marketlog. All Rights Reserved.
